With regard to the skin disorders, when compared to gemcitabine alone, the higher risk was observed in the combination fluoropyrimidine and gemcitabine, as well as in the combination of EGFR inhibitors and gemcitabine. This evidence concerns the gene EGFR and skin disorder.